title: Inhibitor questions: plasma-derived factor VIII and recombinant factor VIII.
authors.affiliation: Baxter Biotech., Hyland Division, Glendale, CA.
authors.forename: G
authors.initials: G
authors.lastname: Bray
mesh_terms: D000328:Adult; D000818:Animals; D016466:CHO Cells; D002648:Child; D006224:Cricetinae; D005169:Factor VIII / Q000009:adverse effects / Q000302:isolation & purification / Q000627:therapeutic use*; D006467:Hemophilia A / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007668:Kidney; D011994:Recombinant Proteins / Q000009:adverse effects / Q000302:isolation & purification / Q000627:therapeutic use*; D014162:Transfection
chemical_list: D011994:Recombinant Proteins; C078147:F8 protein, human; D005169:Factor VIII